Great value diamond pass includes a choice of one of efp's latest Reports including...

Pharma Emerging Markets Report 2012

New for 2011 this report outlines successful strategies to grow your brand in Pharma Emerging Markets - BRICM.

Breaking into Emerging Markets is increasingly becoming the secret to success within Pharma however; there is still a lot of confusion clouding growth potential. To make the most of emerging markets it is now vital to get a grasp on the real trends shaping these markets in order to define new opportunities and assess likely threats.

This ground breaking business intelligence report offers you an up to the minute and digestible view of where emerging markets are currently as well as, forecasting growth in both population size and healthcare investment over a five year period.

Based on information gathered from more than 20 interviews with industry executive's working within the emerging markets themselves, and further supported by Global Demographics Healthcare Ltd data, this is your exclusive guide to understanding and utilizing BRICM countries.

The reports key insights include...

  • Simplified overviews of these markets including a showcase of success secrets.
  • Focused knowledge and strategy to engage effectively with rapidly changing emerging markets.
  • Valuable information from case studies on the sales and marketing strategies in line with the unique regulatory and customer demands of each markets most challenging & inevitably valuable areas.
  • An understanding of your marketing effectiveness in relation to your peers.

Featuring Contributions From:

Astra Zeneca

Guillermo Arvizu
Institutional Business Head
AstraZeneca

Janssen

Olga Bogdanovich
Sales and Operations Analytics Manager
Janssen

Takeda

Andre Bortoluci Vicente
Market Access Group Manager
Takeda

Bayer

Rafael Quintanilla Chong
Director of Bayer's Primary Care Business Unit
Bayer

UCB

Daniel Ghozzi
Managing Director for the Commonwealth of Independent States
UCB

Glenmark

Carlos Grzelak. Jr
Sales and Marketing Director
Glenmark

Johnson_and_Johnson

Pauline Ho, Consultant at AuPATH LLC & former VP, Strategic Marketing, Latin America and Asia-Pacific
Johnson & Johnson

Merck

Alberto Jaimes
National Sales Manager
Merck

Corporate Law Group

Rajashree Sharma
Partner
Corporate Law Group

Sanofi-Aventis

Rogerio Sperb
Insulin Marketing Manager
Sanofi-Aventis

Merck

Bhavesh Vyas
Regional Sales Manager
Merck

Ricerca Biosciences

Dr Susan Wang
Strategic Director
Ricerca Biosciences


Peer Reviewed By:

The report from eyeforpharma on the BRICM markets is an excellent overview based on interviews with country experts, offering a quick snapshot of the current state of five countries' pharmaceutical markets, their growth opportunities and real life case studies. As the world becomes ever more connected and the pace of change ever more vertiginous, successful companies are those that are not afraid to confess that they don't know it all, and are continuously pursuing and experimenting with new knowledge to maximise growth. This report provides marketing and sales insights to increasing the odds in succeeding in these fast growing emerging markets
Pauline Ho
Pauline Ho,
Former VP, Strategic Marketing, Latin America and Asia-Pacific, Johnson & Johnson.
Currently Consultant, AuPATH LLC.


This report is perfect to accompany the knowledge and contacts gained at SFE EU 2012. To get the edge over your competitors today

To get a sneak preview of what our vigorous research has found as well as see in more detail what is included, download the reports FREE selected findings.

Purchase your diamond pass here
Purchase Your Pass Now

Sponsors